FRM
TECX

Fox Run Management’s Tectonic Therapeutic TECX Stock Holding History

Fox Run Management’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
+8,865
New +$260K 0.05% 666

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Fox Run Management's TECX Position: Q2 2026 in Review

Fox Run Management opened a new position in Tectonic Therapeutic (TECX) in Q2 2026: 8,865 shares worth $305K. The stake represents 0.05% of the portfolio and ranks #666 among its holdings.

123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Fox Run Management held 8,865 shares of Tectonic Therapeutic worth $305K as of Q2 2026.
  • Tectonic Therapeutic was a new Fox Run Management position in Q2 2026.
  • Tectonic Therapeutic made up 0.05% of Fox Run Management's portfolio in Q2 2026, its #666 holding.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.